跳至主要内容
临床试验/EUCTR2011-000059-17-DK
EUCTR2011-000059-17-DK进行中(未招募)不适用

The clinical significance of acid rebound: Symptoms of reflux after 8 weeks of PPI treatment in patients with functional dyspepsia.

Koege Hospital0 个研究点开始时间: 2011年2月11日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 18 years +
  • Symptoms of dyspepsia, which GP consider would benefit from PPI treatment.
  • Access to internet.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Signs of severe pathology (extreme weight loss ect.)
  • Symptoms of GORD four weeks before enrolment, according to the Montreal definition.
  • Abnormal pH profile prior to enrolment or at screening.
  • Treatment with PPI or H2-blockers on a regular basis the last year before enrolment
  • Previous surgery on esophagus, stomach or duodenum
  • Use of NSAIDs, antacids, anti-depressives and other analgesics on a regular basis
  • Potential language problems in understanding information and registering symptoms
  • Pregnancy or breast feeding
  • Other diseases which can interfere with the symptom registration (severe congestive heart disease, malignant disease, schizophrenia ect.).
  • No access to internet.

研究者

发起方
Koege Hospital

相似试验